This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (143) Anxiety and Stress Disorders (1053) Depression and Mood Disorders; Suicide Prevention (1363)

Published on in Vol 9, No 6 (2020): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17223, first published .
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

Authors of this article:

Arthi Chinna Meyyappan1, 2, 3 Author Orcid Image ;   Roumen Milev1, 2, 3, 4 Author Orcid Image
Article Authors Cited by (10) Tweetations (8) Metrics

Arthi Chinna Meyyappan   1, 2, 3 , BScH, MSc ;   Roumen Milev   1, 2, 3, 4 , MD, PhD, FRCPC, FRCPsych

1 Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada

2 Providence Care Hospital, Kingston, ON, Canada

3 Department of Psychiatry, Queen's University, Kingston, ON, Canada

4 Department of Psychology, Queen's University, Kingston, ON, Canada

Corresponding Author: